Open AccessA Rare Pathogen Comamonas Testosteroni: A Case Report and Review of the Literature
Author(s) -
S. Gayenur Buyukberber,
B Orkun Ozbay
Publication year - 2022
Publication title -
japan journal of clinical and medical research
Language(s) - English
Resource type - Journals
ISSN - 2755-0141
DOI - 10.47363/jjcmr/2022(2)134
Subject(s) - comamonas testosteroni , microbiology and biotechnology , meropenem , piperacillin , ciprofloxacin , imipenem , bacteremia , amikacin , ceftazidime , tazobactam , endocarditis , medicine , biology , antibiotics , pseudomonas aeruginosa , antibiotic resistance , bacteria , genetics
Comamonas testosteroni is a Gram- negative, aerobic, motile, non-spore-forming bacillus. It has not been recognized as a component of the endogenous human microflora. Due to its ability to survive in liquid environments, it can survive for a long time in a hospital environment and cause opportunistic infections. Although rare, C. testosteroni has been reported as a cause of cellulitis, peritonitis, endocarditis, meningitis, endophthalmitis, tenosynovitis, pneumonia and bacteremia. Here, we present a case of a 4-yearold girl who was operated on for persistent cloaca with C. testosteroni isolated in her urine culture. Identification studies were performed by MALDI-TOF MS (bioMerieux, France) mass spectrophotometer method. Antibiotic susceptibility tests were performed with the automatic device VITEK-2 Compact (bioMérieux, France). Microorganism was found susceptible to ceftazidime and ciprofloxacin; intermediate susceptible to meropenem and piperacillin / tazobactam and resistant to gentamicin, amikacin, imipenem and trimethoprim-sulfamethoxazole. With this case report, C. testosteroni was reported as the first cause of urinary tract infection in our country and the third in the world.